CSI Pharmacy Sets New Industry Standards in Immunoglobulin Certification for Nurses
CSI Pharmacy, a renowned specialty infusion pharmacy located in Texas, continues to make waves in the healthcare sector by advancing its specialists' qualifications in immunoglobulin (Ig) therapy. This past November, the pharmacy proudly announced that 14 of its nurses and pharmacists achieved Ig certification through the Immunoglobulin National Society (IgNS). This certification not only highlights the expertise of their clinical team but also underscores CSI’s unwavering commitment to delivering top-notch care to patients suffering from rare and chronic conditions.
Founded in 2014, CSI Pharmacy has set its sights on establishing a benchmark of excellence in Ig therapy. As the first corporate member of IgNS, CSI has been pivotal in promoting enhanced standards of Ig administration across the healthcare industry. According to James Sheets, PharmD, and the founder and CEO of CSI, the organization is deeply committed to bolstering Ig therapy capabilities. ‘We are dedicated to advancing Ig therapy for both patients and communities,’ he states. ‘We constantly invest in our team’s expertise to elevate their proficiency in this specialized area of infusion therapy.’
The complexity surrounding Ig therapy necessitates a high level of clinical acumen. The certification process led by IgNS meticulously evaluates the competencies of nurses and pharmacists and stands as the only nationally recognized standard in the realm of Ig therapy. Achieving this certification is a testament to the rigorous requirements for knowledge and experience that these healthcare professionals must meet to provide competent Ig care.
Dr. Luba Sobolevsky, IgCP® and president of IgNS, emphasizes the intricate nature of Ig therapy: ‘It demands that clinicians possess advanced skills to ensure safe practices and optimal patient outcomes. Obtaining the prestigious IgCN® and IgCP® credentials is a symbol of the clinician's commitment to their profession, acknowledging their profound knowledge and clinical expertise.’
For CSI Pharmacy, certifying its clinical staff reinforces its status as a leader in managing patients with intricate immune disorders, thereby ensuring exceptional care. ‘Our belief in the certification process reflects our commitment to delivering the best therapies and outcomes for our patients. Ensuring the highest education and training for our team is paramount,’ shares Sheets.
CSI Pharmacy is nationally recognized for its specialization in treating chronic and rare illnesses. Established by pharmacists with a vision to improve health outcomes, the pharmacy focuses on biologics and plasma-derived therapies and employs infusion nurses trained specifically for patient care. With licenses in 49 states and Washington, D.C., as well as accreditations from prestigious bodies such as the Accreditation Commission for Health Care (ACHC) and URAC, CSI Pharmacy stands at the forefront of innovation in specialty pharmacy.
As the company advances, its dedication to excellence in Ig therapy not only enhances the credentials of its team but also profoundly impacts the lives of patients in need. Through its initiative, CSI Pharmacy is reshaping the landscape of Ig therapy and setting new standards for care and professionalism in the field. With continued focus on education and growth, the pharmacy not only promises exceptional treatment outcomes but also paves the way for future advancements in immunoglobulin therapy across the country.
Founded in 2014, CSI Pharmacy has set its sights on establishing a benchmark of excellence in Ig therapy. As the first corporate member of IgNS, CSI has been pivotal in promoting enhanced standards of Ig administration across the healthcare industry. According to James Sheets, PharmD, and the founder and CEO of CSI, the organization is deeply committed to bolstering Ig therapy capabilities. ‘We are dedicated to advancing Ig therapy for both patients and communities,’ he states. ‘We constantly invest in our team’s expertise to elevate their proficiency in this specialized area of infusion therapy.’
The complexity surrounding Ig therapy necessitates a high level of clinical acumen. The certification process led by IgNS meticulously evaluates the competencies of nurses and pharmacists and stands as the only nationally recognized standard in the realm of Ig therapy. Achieving this certification is a testament to the rigorous requirements for knowledge and experience that these healthcare professionals must meet to provide competent Ig care.
Dr. Luba Sobolevsky, IgCP® and president of IgNS, emphasizes the intricate nature of Ig therapy: ‘It demands that clinicians possess advanced skills to ensure safe practices and optimal patient outcomes. Obtaining the prestigious IgCN® and IgCP® credentials is a symbol of the clinician's commitment to their profession, acknowledging their profound knowledge and clinical expertise.’
For CSI Pharmacy, certifying its clinical staff reinforces its status as a leader in managing patients with intricate immune disorders, thereby ensuring exceptional care. ‘Our belief in the certification process reflects our commitment to delivering the best therapies and outcomes for our patients. Ensuring the highest education and training for our team is paramount,’ shares Sheets.
CSI Pharmacy is nationally recognized for its specialization in treating chronic and rare illnesses. Established by pharmacists with a vision to improve health outcomes, the pharmacy focuses on biologics and plasma-derived therapies and employs infusion nurses trained specifically for patient care. With licenses in 49 states and Washington, D.C., as well as accreditations from prestigious bodies such as the Accreditation Commission for Health Care (ACHC) and URAC, CSI Pharmacy stands at the forefront of innovation in specialty pharmacy.
As the company advances, its dedication to excellence in Ig therapy not only enhances the credentials of its team but also profoundly impacts the lives of patients in need. Through its initiative, CSI Pharmacy is reshaping the landscape of Ig therapy and setting new standards for care and professionalism in the field. With continued focus on education and growth, the pharmacy not only promises exceptional treatment outcomes but also paves the way for future advancements in immunoglobulin therapy across the country.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.